查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1830962

蛋白質體學市場

Proteomics Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

蛋白質體學市場預計將大幅成長，預計將從 2024 年的 345.6 億美元成長到 2031 年的 859.1 億美元，2025 年至 2031 年的複合年成長率為 11.9%。

分析師觀點：本報告概述了基於蛋白質組學市場當前趨勢及其在預測期內的預期影響的成長機會。蛋白質體學涉及對蛋白質組的廣泛研究，蛋白質組是由生物體產生的蛋白質的集合。蛋白質組是動態的，在不同細胞之間有所不同，並隨時間而變化。它提供了對底層轉錄組的深入了解，轉錄組涵蓋了生物體中的所有信使RNA分子。除了基因表現量之外，還有許多因素會影響蛋白質活性。蛋白質體學的應用非常廣泛，由於個人化醫療需求的不斷成長以及該領域研發的不斷增加，預計市場將大幅擴張。然而，嚴格的監管要求和熟練專業人員的短缺可能會阻礙市場成長。

市場概覽：蛋白質體學是對蛋白質結構和功能的綜合研究。它包括快速發展的疾病蛋白質組學領域，該領域旨在識別與人類疾病相關的蛋白質，並了解其表達、結構和功能如何導致疾病。蛋白質體學市場成長的關鍵促進因素包括癌症和其他疾病發生率的上升。正在進行的蛋白質組學研究透過提供關鍵的生物標記資訊，幫助醫療保健專業人員了解蛋白質在動態環境中的行為，例如在癌症患者體內。此外，奈米蛋白質組學的進步預計將在未來幾年對市場成長產生積極影響。

策略洞察市場促進因素：慢性病發生率上升推動市場擴張。癌症、呼吸系統疾病、慢性腎臟病 (CKD) 和心血管疾病 (CVD) 等慢性病的盛行率不斷上升，預計將成為推動市場成長的重要因素。例如，Globocan 報告稱，2020 年 12 月全球新增癌症病例約 1,930 萬例，癌症相關死亡人數達 1,000 萬人。心血管疾病也是全球主要死因之一，世界衛生組織 (WHO) (2021) 指出，這些疾病每年造成 4,100 萬人死亡。危及生命的疾病發病率不斷上升，推動了對個人化治療的需求，這對該行業產生了積極影響。

隨著全球人口中很大一部分與癌症作鬥爭，對有效治療的需求激增。生命科學領域正在取得許多突破，人類蛋白質的表徵標誌著生物醫學的重大進步。在蛋白質組層面評估基因表現至關重要。該領域的持續研發預計將推動蛋白質體學市場的大幅成長，因為這項技術可以提供重要的生物學見解，增強我們對癌症生物學的理解。慢性病盛行率的上升進一步擴大了對蛋白質體學的需求。

分段分析：透過檢查以下分段來分析蛋白質體學市場：產品和服務、應用和最終用戶。

就產品和服務而言，蛋白質體學市場分為儀器技術、試劑和耗材以及軟體和服務。試劑和耗材細分市場在2022年佔據市場主導地位，預計在2022年至2030年期間將達到14.1%的最高複合年成長率。這一成長歸因於研究機構和大學在研究各種生物材料時對試劑、試劑盒、耗材和試紙的使用日益增加。此外，政府支持蛋白質組學和基因組學的舉措，以及疾病診斷研究活動的加強，預計將推動市場成長。此外，3D電泳蛋白分析儀等先進儀器的進步，提高了生物研究的速度、效率和生產力，也將有助於市場擴張。

根據應用，市場細分為臨床診斷、藥物研發和其他領域。臨床診斷領域在2022年佔據了蛋白質體學市場的最大佔有率，因為研究人員和臨床醫生經常利用蛋白質分析來識別疾病生物標記物，從而進行早期風險因素檢測。基於蛋白質體學的診斷方法還可以揭示潛在的蛋白質轉錄調控，有助於惡性腫瘤的識別和預後。

就最終用戶而言，蛋白質體學市場分為製藥和生物技術公司、研究和臨床實驗室、醫院和其他。製藥和生物技術公司在2022年佔據了最大的市場佔有率。然而，預計研究和臨床實驗室在2022年至2030年期間的複合年成長率最高，為14.5%。製藥和生物技術公司為開發創新藥物而增加的研發資金可能會推動對蛋白質體學服務的需求。此外，研發活動的加強、針對各種危及生命疾病的蛋白質體學研究的持續進行以及學術和研究環境中生命科學計畫的增加，也推動了對酵素、試劑和試劑盒的需求。

區域分析：蛋白質體學市場報告涵蓋北美、歐洲、亞太地區、中東和非洲以及南美和中美。北美市場在 2022 年的價值為 119.5 億美元，預計到 2030 年將達到 335.6 億美元，2022 年至 2030 年的複合年成長率為 13.8%。推動該地區市場成長的關鍵因素包括對基於結構的藥物設計投資的增加、對高品質資料可重複性研究工具的需求以及組學研究的成長。人們專注於開發個人化治療，主要區域公司之間的合作也有助於擴大市場。例如，賽默飛世爾科技公司和 Symphogen 合作創建了經過驗證的平台流程，用於最佳化複雜治療蛋白質的表徵和品質監測。目前，許多蛋白質療法正在進行癌症、感染、免疫疾病、與年齡相關的疾病和其他疾病的臨床試驗。此外，由於美國阿茲海默症等遺傳疾病以及瘧疾和結核病等傳染病的高發病率，蛋白質體學研究在美國蓬勃發展。

亞太地區蛋白質體學市場預計將實現最快的複合年成長率，達到14.3%。該地區，尤其是印度和中國等國家，擁有龐大的製藥產業，而中國則是製藥製造中心。該地區預期的市場成長得益於其擁有功能齊全的製造部門和合約製造設施。此外，大量易患癌症和其他傳染病的人群、蛋白質體學在診斷遺傳疾病中的廣泛應用以及研發支出和社會項目的增加，預計將推動基於蛋白質組的疾病診斷需求，從而促進市場成長。

蛋白質體學市場報告範圍關鍵參與者分析：蛋白質組學市場報告中介紹的關鍵參與者包括 Proteome Sciences、Biognosys、Creative Proteomics、Shantani、Olink、SomaLogic Operating Co., Inc.、QUANTUM-SI INCORPORATED、Proteomics International、Promise Proteomics、SCII.

最新動態：蛋白質體學市場中的公司正在將併購作為關鍵的成長策略。市場的最新動態包括：

2022年6月，SomaLogic與Illumina公司宣布達成聯合開發協議，將在Illumina現有及未來的高通量新一代定序(NGS)平台上應用SomaScan蛋白質組學檢測試劑盒，加速快速成長的蛋白質組學市場中新一代定序技術的發展。 2022年5月，Proteomics International Laboratories Ltd獲得13,516美元融資，用於在澳洲生產其PromarkerD臨床診斷試劑盒，這是第一個針對糖尿病相關腎病變的診斷預測檢測。該計劃旨在促進新的健康創新，推動相關發現向概念驗證和商業化方向發展，從而應對重大健康挑戰，並最大限度地發揮創業潛力。

目錄

第1章：引言

第2章：關鍵要點

第3章：研究方法

第4章：蛋白質體學市場格局

  • 概述
  • 害蟲分析
    • 北美 - 害蟲分析
    • 歐洲 - 害蟲分析
    • 亞太地區 - 害蟲分析
    • 中東和非洲 - 害蟲分析
    • 南美洲和中美洲 - 害蟲分析
  • 專家意見

第5章：蛋白質體學市場－主要市場動態

  • 主要市場促進因素
  • 主要市場限制因素
  • 主要市場機會
  • 未來趨勢
  • 促進因素和約束因素的影響分析

第6章：蛋白質體學市場－全球市場分析

  • 蛋白質體學—全球市場概覽
  • 蛋白質體學－全球市場及2028年預測
  • 市場定位

第7章：蛋白質體學市場－2028 年營收及預測－儀器

  • 概述
  • 儀器市場預測與分析
  • 光譜學
    • 概述
    • 光譜市場預測與分析
    • 質譜市場
      • 概述
      • 質譜市場預測與分析
    • 核磁共振光譜市場
      • 概述
      • 核磁共振光譜市場預測與分析
    • 圓二色性（CD）光譜市場
      • 概述
      • 圓二色性（CD）光譜市場預測與分析
  • 色譜法
    • 概述
    • 色譜市場預測與分析
    • HPLC市場
      • 概述
      • HPLC市場預測與分析
    • 離子色譜市場
      • 概述
      • 離子色譜市場預測與分析
    • 離子色譜市場
      • 概述
      • 離子色譜市場預測與分析
    • 超臨界流體層析市場
      • 概述
      • 超臨界流體色譜市場預測與分析
  • 電泳
    • 概述
    • 電泳市場預測與分析
    • 凝膠電泳市場
      • 概述
      • 凝膠電泳市場預測與分析
    • 毛細管電泳市場
      • 概述
      • 毛細管電泳市場預測與分析
  • 蛋白質微陣列
    • 概述
    • 蛋白質微陣列市場預測與分析
    • 生物晶片市場
      • 概述
      • 生物晶片市場預測與分析
    • 微陣列儀器市場
      • 概述
      • 微陣列儀器市場預測與分析
  • X光晶體學
    • 概述
    • X光晶體學市場預測與分析
  • 表面等離子體共振
    • 概述
    • 表面等離子體共振市場預測與分析
  • 蛋白質分餾
    • 概述
    • 蛋白質分餾市場預測與分析
  • 其他樂器
    • 概述
    • 其他儀器市場預測與分析

第 8 章：蛋白質體學市場 - 收入與預測（至 2028 年）- 試劑

  • 概述
  • 試劑市場預測與分析
  • 免疫分析試劑
    • 概述
    • 免疫分析試劑市場預測與分析
  • 光譜試劑
    • 概述
    • 光譜試劑市場預測與分析
  • 色譜試劑
    • 概述
    • 色譜試劑市場預測與分析
  • 蛋白質微陣列試劑
    • 概述
    • 蛋白質微陣列試劑市場預測與分析
  • X光晶體學試劑
    • 概述
    • X光晶體學試劑市場預測與分析
  • 電泳試劑
    • 概述
    • 電泳試劑市場預測與分析
  • 蛋白質分離試劑
    • 概述
    • 蛋白質分離試劑市場預測與分析

第9章：蛋白質體學市場－2028年營收及預測－服務與軟體

  • 概述
  • 服務與軟體市場預測與分析
  • 服務
    • 概述
    • 服務市場預測與分析
    • 蛋白質鑑定服務市場
      • 概述
      • 蛋白質鑑定服務市場預測與分析
    • 定量蛋白質體學服務市場
      • 概述
      • 定量蛋白質體學服務市場預測與分析
    • 蛋白質純化服務市場
      • 概述
      • 蛋白質純化服務市場預測與分析
    • 蛋白質分離服務市場
      • 概述
      • 蛋白質分離服務市場預測與分析
    • 蛋白質定序服務市場
      • 概述
      • 蛋白質定序服務市場預測與分析
    • 其他服務市場
      • 概述
      • 其他服務市場預測與分析
  • 軟體
    • 概述
    • 軟體市場預測與分析
    • 生物資訊服務市場
      • 概述
      • 生物資訊服務市場預測與分析
    • 生物資訊工具市場
      • 概述
      • 生物資訊工具市場預測與分析
    • 生物資訊資料庫市場
      • 概述
      • 生物資訊資料庫市場預測與分析

第 10 章：蛋白質體學市場 - 收入和預測至 2028 年 - 應用

  • 概述
  • 應用市場預測與分析
  • 臨床診斷
    • 概述
    • 臨床診斷市場預測與分析
  • 藥物研發
    • 概述
    • 藥物研發市場預測與分析
  • 其他應用
    • 概述
    • 其他應用市場預測與分析

第 11 章：蛋白質體學市場收入和預測到 2028 年 - 地理分析

  • 北美洲
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 歐洲
      • 德國
      • 法國
      • 義大利
      • 西班牙
      • 英國
      • 歐洲其他地區
  • 亞太
    • 亞太
      • 澳洲
      • 中國
      • 印度
      • 日本
      • 韓國
      • 亞太其他地區
  • 中東和非洲
    • 中東和非洲
      • 南非
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 中東和非洲其他地區
  • 南美洲和中美洲
    • 南美洲和中美洲
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地區

第 12 章：COVID-19 大流行對全球蛋白質體學市場的影響

  • 北美洲
  • 歐洲
  • 亞太
  • 中東和非洲
  • 南美洲和中美洲

第13章：產業格局

  • 併購
  • 協議、合作和合資企業
  • 新產品發布
  • 擴張和其他策略發展

第 14 章：蛋白質體學市場、主要公司簡介

  • THERMO FISHER SCIENTIFIC INC.
  • BIO-RAD LABORATORIES, INC.
  • AGILENT TECHNOLOGIES
  • DANAHER
  • PERKINELMER INC.
  • MERCK KGAA
  • LUMINEX CORPORATION
  • GENERAL ELECTRIC COMPANY
簡介目錄
Product Code: TIPHE100001115

The proteomics market is anticipated to grow significantly, with projections indicating an increase from US$ 34.56 billion in 2024 to US$ 85.91 billion by 2031, reflecting a CAGR of 11.9% from 2025 to 2031.

Analyst Perspective:This report outlines growth opportunities based on current trends in the proteomics market and their expected effects during the forecast period. Proteomics involves the extensive study of proteomes, which are collections of proteins produced by a biological entity. A proteome is dynamic, varying from one cell to another and changing over time. It provides insights into the underlying transcriptome, which encompasses all messenger RNA molecules in an organism. Various factors, beyond just gene expression levels, affect protein activity. The applications of proteomics are vast, and the market is projected to expand significantly due to rising demand for personalized medicine and increased research and development in the field. However, stringent regulatory requirements and a shortage of skilled professionals may hinder market growth.

Market Overview:Proteomics is the comprehensive study of protein structures and functions. It includes the rapidly advancing area of disease proteomics, which seeks to identify proteins associated with human diseases and understand how their expression, structure, and function contribute to disease. Key drivers of growth in the proteomics market include the rising incidence of cancer and other diseases. Ongoing proteomics research aids healthcare professionals in understanding protein behavior in dynamic environments, such as in cancer patients, by providing critical biomarker information. Moreover, advancements in nano proteomics are expected to positively influence market growth in the coming years.

Strategic Insights Market Driver: Rising Incidence of Chronic Diseases Fuels Market Expansion

The increasing prevalence of chronic diseases, including cancer, respiratory illnesses, chronic kidney disease (CKD), and cardiovascular diseases (CVDs), is a significant factor anticipated to drive market growth. For instance, Globocan reported approximately 19.3 million new cancer cases globally in December 2020, with 10 million cancer-related deaths. Cardiovascular diseases are also among the leading causes of death worldwide, with the WHO (2021) noting that these diseases account for 41 million deaths annually. The rising incidence of life-threatening diseases is driving demand for personalized therapies, which positively impacts the industry.

As a significant portion of the global population battles cancer, the demand for effective treatments has surged. Numerous breakthroughs are being made in life sciences, with the characterization of human proteins marking a significant advancement in biomedicine. Evaluating gene expression at the proteome level is crucial. Ongoing research and development in this area are expected to lead to substantial growth in the proteomics market, as this technique can yield vital biological insights that enhance our understanding of cancer biology. The increasing prevalence of chronic diseases further amplifies the demand for proteomics.

Segmental Analysis:The analysis of the proteomics market has been conducted by examining the following segments: product & service, application, and end user.

In terms of product & service, the proteomics market is categorized into instrumentation technologies, reagents & consumables, and software & services. The reagents & consumables segment dominated the market in 2022 and is projected to achieve the highest CAGR of 14.1% from 2022 to 2030. This growth is attributed to the increasing utilization of reagents, kits, consumables, and strips for studying various biological materials in research institutions and universities. Additionally, government initiatives supporting proteomics and genomics, along with heightened research activities in disease diagnostics, are expected to drive market growth. Furthermore, advancements in sophisticated instruments, such as 3D electrophoresis protein analyzers, which enhance the speed, efficiency, and productivity of biological research, will also contribute to market expansion.

By application, the market is segmented into clinical diagnostics, drug discovery & development, and others. The clinical diagnostics segment held the largest share of the proteomics market in 2022, as researchers and clinicians frequently utilize protein analysis to identify disease biomarkers for early risk factor detection. Proteomics-based diagnostics can also uncover potential protein transcription regulation, aiding in the identification and prognosis of malignancies.

Regarding end users, the proteomics market is divided into pharmaceutical & biotechnology companies, research & clinical laboratories, hospitals, and others. The pharmaceutical & biotechnology companies segment accounted for the largest market share in 2022. However, the research & clinical laboratories segment is expected to experience the highest CAGR of 14.5% from 2022 to 2030. Increased R&D funding from pharmaceutical and biotechnology firms aimed at developing innovative drugs is likely to drive demand for proteomics services. Additionally, the need for enzymes, reagents, and kits is being fueled by heightened research and development activities, ongoing proteomics studies targeting various life-threatening diseases, and increased life science projects in academic and research settings.

Regional Analysis:The proteomics market report encompasses North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The North American market was valued at US$ 11.95 billion in 2022 and is projected to reach US$ 33.56 billion by 2030, with an expected CAGR of 13.8% from 2022 to 2030. Key factors driving market growth in this region include increased investments in structure-based drug design, demand for high-quality research tools for data reproducibility, and growth in omics research. There is a focus on developing personalized treatments, and partnerships among major regional companies also contribute to market expansion. For example, Thermo Fisher Scientific Inc. and Symphogen have collaborated to create verified platform processes for the optimized characterization and quality monitoring of complex therapeutic proteins. Numerous protein therapies are currently undergoing clinical trials for cancer, infections, immunological disorders, age-related diseases, and other conditions. Additionally, proteomics research is thriving in the US, driven by the high incidence of inherited diseases like Alzheimer's and infectious diseases such as malaria and tuberculosis in the region.

The Asia Pacific proteomics market is expected to exhibit the fastest CAGR of 14.3%. This region, particularly countries like India and China, boasts a substantial pharmaceutical industry, with China serving as a hub for pharmaceutical manufacturing. The anticipated market growth in this region is attributed to the presence of highly functional manufacturing units and contract manufacturing facilities. Furthermore, a large population susceptible to cancer and other infectious diseases, extensive use of proteomics in diagnosing genetic disorders, and increased R&D spending and social programs are expected to drive the demand for proteome-based disease diagnosis, thereby enhancing market growth.

Proteomics Market Report Scope Key Player Analysis:Key players profiled in the proteomics market report include Proteome Sciences, Biognosys, Creative Proteomics, Shantani, Olink, SomaLogic Operating Co., Inc., QUANTUM-SI INCORPORATED, Proteomics International, Promise Proteomics, SCIEX, Illumina, Inc., and Thermo Fisher Scientific Inc.

Recent Developments:Companies in the proteomics market are pursuing mergers and acquisitions as key growth strategies. Recent developments in the market include:

In June 2022, SomaLogic and Illumina, Inc. announced a joint development agreement to utilize the SomaScan Proteomics Assay on Illumina's current and future high-throughput next-generation sequencing (NGS) platforms, accelerating next-generation sequencing in the rapidly growing proteomics market.

In May 2022, Proteomics International Laboratories Ltd secured US$ 13,516 in funding to facilitate the production of its PromarkerD clinical diagnostic in Australia, the first diagnostic predictive test for diabetes-related kidney disease. This initiative aims to foster new health innovations and advance discoveries toward proof-of-concept and commercialization that address significant health challenges and maximize entrepreneurial potential.

Table Of Contents

1. INTRODUCTION

  • 1.1. SCOPE OF THE STUDY
  • 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
  • 1.3. MARKET SEGMENTATION
    • 1.3.1 Proteomics Market - By Instrument
    • 1.3.2 Proteomics Market - By Reagents
    • 1.3.3 Proteomics Market - By Services and Software
    • 1.3.4 Proteomics Market - By Application
    • 1.3.5 Proteomics Market - By Region
      • 1.3.5.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PROTEOMICS MARKET LANDSCAPE

  • 4.1. OVERVIEW
  • 4.2. PEST ANALYSIS
    • 4.2.1 North America - Pest Analysis
    • 4.2.2 Europe - Pest Analysis
    • 4.2.3 Asia-Pacific - Pest Analysis
    • 4.2.4 Middle East and Africa - Pest Analysis
    • 4.2.5 South and Central America - Pest Analysis
  • 4.3. EXPERT OPINIONS

5. PROTEOMICS MARKET - KEY MARKET DYNAMICS

  • 5.1. KEY MARKET DRIVERS
  • 5.2. KEY MARKET RESTRAINTS
  • 5.3. KEY MARKET OPPORTUNITIES
  • 5.4. FUTURE TRENDS
  • 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PROTEOMICS MARKET - GLOBAL MARKET ANALYSIS

  • 6.1. PROTEOMICS - GLOBAL MARKET OVERVIEW
  • 6.2. PROTEOMICS - GLOBAL MARKET AND FORECAST TO 2028
  • 6.3. MARKET POSITIONING

7. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - INSTRUMENT

  • 7.1. OVERVIEW
  • 7.2. INSTRUMENT MARKET FORECASTS AND ANALYSIS
  • 7.3. SPECTROSCOPY
    • 7.3.1. Overview
    • 7.3.2. Spectroscopy Market Forecast and Analysis
    • 7.3.3. Mass Spectroscopy Market
      • 7.3.3.1. Overview
      • 7.3.3.2. Mass Spectroscopy Market Forecast and Analysis
    • 7.3.4. NMR Spectroscopy Market
      • 7.3.4.1. Overview
      • 7.3.4.2. NMR Spectroscopy Market Forecast and Analysis
    • 7.3.5. Circular Dichroism (CD) Spectroscopy Market
      • 7.3.5.1. Overview
      • 7.3.5.2. Circular Dichroism (CD) Spectroscopy Market Forecast and Analysis
  • 7.4. CHROMATOGRAPHY
    • 7.4.1. Overview
    • 7.4.2. Chromatography Market Forecast and Analysis
    • 7.4.3. HPLC Market
      • 7.4.3.1. Overview
      • 7.4.3.2. HPLC Market Forecast and Analysis
    • 7.4.4. Ion Chromatography Market
      • 7.4.4.1. Overview
      • 7.4.4.2. Ion Chromatography Market Forecast and Analysis
    • 7.4.5. Ion Chromatography Market
      • 7.4.5.1. Overview
      • 7.4.5.2. Ion Chromatography Market Forecast and Analysis
    • 7.4.6. Supercritical Fluid Chromatography Market
      • 7.4.6.1. Overview
      • 7.4.6.2. Supercritical Fluid Chromatography Market Forecast and Analysis
  • 7.5. ELECTROPHORESIS
    • 7.5.1. Overview
    • 7.5.2. Electrophoresis Market Forecast and Analysis
    • 7.5.3. Gel Electrophoresis Market
      • 7.5.3.1. Overview
      • 7.5.3.2. Gel Electrophoresis Market Forecast and Analysis
    • 7.5.4. Capillary Electrophoresis Market
      • 7.5.4.1. Overview
      • 7.5.4.2. Capillary Electrophoresis Market Forecast and Analysis
  • 7.6. PROTEIN MICROARRAYS
    • 7.6.1. Overview
    • 7.6.2. Protein Microarrays Market Forecast and Analysis
    • 7.6.3. Biochips Market
      • 7.6.3.1. Overview
      • 7.6.3.2. Biochips Market Forecast and Analysis
    • 7.6.4. Microarray Instruments Market
      • 7.6.4.1. Overview
      • 7.6.4.2. Microarray Instruments Market Forecast and Analysis
  • 7.7. X-RAY CRYSTALLOGRAPHY
    • 7.7.1. Overview
    • 7.7.2. X-Ray Crystallography Market Forecast and Analysis
  • 7.8. SURFACE PLASMON RESONANCE
    • 7.8.1. Overview
    • 7.8.2. Surface Plasmon Resonance Market Forecast and Analysis
  • 7.9. PROTEIN FRACTIONATION
    • 7.9.1. Overview
    • 7.9.2. Protein Fractionation Market Forecast and Analysis
  • 7.10. OTHER INSTRUMENT
    • 7.10.1. Overview
    • 7.10.2. Other Instrument Market Forecast and Analysis

8. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - REAGENTS

  • 8.1. OVERVIEW
  • 8.2. REAGENTS MARKET FORECASTS AND ANALYSIS
  • 8.3. IMMUNOASSAY REAGENTS
    • 8.3.1. Overview
    • 8.3.2. Immunoassay Reagents Market Forecast and Analysis
  • 8.4. SPECTROSCOPY REAGENTS
    • 8.4.1. Overview
    • 8.4.2. Spectroscopy Reagents Market Forecast and Analysis
  • 8.5. CHROMATOGRAPHY REAGENTS
    • 8.5.1. Overview
    • 8.5.2. Chromatography Reagents Market Forecast and Analysis
  • 8.6. PROTEIN MICROARRAY REAGENTS
    • 8.6.1. Overview
    • 8.6.2. Protein Microarray Reagents Market Forecast and Analysis
  • 8.7. X-RAY CRYSTALLOGRAPHY REAGENTS
    • 8.7.1. Overview
    • 8.7.2. X-Ray Crystallography Reagents Market Forecast and Analysis
  • 8.8. ELECTROPHORESIS REAGENTS
    • 8.8.1. Overview
    • 8.8.2. Electrophoresis Reagents Market Forecast and Analysis
  • 8.9. PROTEIN FRACTIONATION REAGENTS
    • 8.9.1. Overview
    • 8.9.2. Protein Fractionation Reagents Market Forecast and Analysis

9. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - SERVICES AND SOFTWARE

  • 9.1. OVERVIEW
  • 9.2. SERVICES AND SOFTWARE MARKET FORECASTS AND ANALYSIS
  • 9.3. SERVICES
    • 9.3.1. Overview
    • 9.3.2. Services Market Forecast and Analysis
    • 9.3.3. Protein Identification Services Market
      • 9.3.3.1. Overview
      • 9.3.3.2. Protein Identification Services Market Forecast and Analysis
    • 9.3.4. Quantitative Proteomics Services Market
      • 9.3.4.1. Overview
      • 9.3.4.2. Quantitative Proteomics Services Market Forecast and Analysis
    • 9.3.5. Protein Purification Services Market
      • 9.3.5.1. Overview
      • 9.3.5.2. Protein Purification Services Market Forecast and Analysis
    • 9.3.6. Protein Separation Services Market
      • 9.3.6.1. Overview
      • 9.3.6.2. Protein Separation Services Market Forecast and Analysis
    • 9.3.7. Protein Sequencing Services Market
      • 9.3.7.1. Overview
      • 9.3.7.2. Protein Sequencing Services Market Forecast and Analysis
    • 9.3.8. Others Services Market
      • 9.3.8.1. Overview
      • 9.3.8.2. Others Services Market Forecast and Analysis
  • 9.4. SOFTWARE
    • 9.4.1. Overview
    • 9.4.2. Software Market Forecast and Analysis
    • 9.4.3. Bioinformatics Services Market
      • 9.4.3.1. Overview
      • 9.4.3.2. Bioinformatics Services Market Forecast and Analysis
    • 9.4.4. Bioinformatics Tools Market
      • 9.4.4.1. Overview
      • 9.4.4.2. Bioinformatics Tools Market Forecast and Analysis
    • 9.4.5. Bioinformatics Databases Market
      • 9.4.5.1. Overview
      • 9.4.5.2. Bioinformatics Databases Market Forecast and Analysis

10. PROTEOMICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION

  • 10.1. OVERVIEW
  • 10.2. APPLICATION MARKET FORECASTS AND ANALYSIS
  • 10.3. CLINICAL DIAGNOSTICS
    • 10.3.1. Overview
    • 10.3.2. Clinical Diagnostics Market Forecast and Analysis
  • 10.4. DRUG DISCOVERY
    • 10.4.1. Overview
    • 10.4.2. Drug Discovery Market Forecast and Analysis
  • 10.5. OTHER APPLICATIONS
    • 10.5.1. Overview
    • 10.5.2. Other Applications Market Forecast and Analysis

11. PROTEOMICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1 North America Proteomics Market Overview
    • 11.1.2 North America Proteomics Market Forecasts and Analysis
    • 11.1.3 North America Proteomics Market Forecasts and Analysis - By Instrument
    • 11.1.4 North America Proteomics Market Forecasts and Analysis - By Reagents
    • 11.1.5 North America Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.1.6 North America Proteomics Market Forecasts and Analysis - By Application
    • 11.1.7 North America Proteomics Market Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Proteomics Market
        • 11.1.7.1.1 United States Proteomics Market by Instrument
        • 11.1.7.1.2 United States Proteomics Market by Reagents
        • 11.1.7.1.3 United States Proteomics Market by Services and Software
        • 11.1.7.1.4 United States Proteomics Market by Application
      • 11.1.7.2 Canada Proteomics Market
        • 11.1.7.2.1 Canada Proteomics Market by Instrument
        • 11.1.7.2.2 Canada Proteomics Market by Reagents
        • 11.1.7.2.3 Canada Proteomics Market by Services and Software
        • 11.1.7.2.4 Canada Proteomics Market by Application
      • 11.1.7.3 Mexico Proteomics Market
        • 11.1.7.3.1 Mexico Proteomics Market by Instrument
        • 11.1.7.3.2 Mexico Proteomics Market by Reagents
        • 11.1.7.3.3 Mexico Proteomics Market by Services and Software
        • 11.1.7.3.4 Mexico Proteomics Market by Application
  • 11.2. EUROPE
    • 11.2.1 Europe Proteomics Market Overview
    • 11.2.2 Europe Proteomics Market Forecasts and Analysis
    • 11.2.3 Europe Proteomics Market Forecasts and Analysis - By Instrument
    • 11.2.4 Europe Proteomics Market Forecasts and Analysis - By Reagents
    • 11.2.5 Europe Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.2.6 Europe Proteomics Market Forecasts and Analysis - By Application
    • 11.2.7 Europe Proteomics Market Forecasts and Analysis - By Countries
      • 11.2.7.1 Germany Proteomics Market
        • 11.2.7.1.1 Germany Proteomics Market by Instrument
        • 11.2.7.1.2 Germany Proteomics Market by Reagents
        • 11.2.7.1.3 Germany Proteomics Market by Services and Software
        • 11.2.7.1.4 Germany Proteomics Market by Application
      • 11.2.7.2 France Proteomics Market
        • 11.2.7.2.1 France Proteomics Market by Instrument
        • 11.2.7.2.2 France Proteomics Market by Reagents
        • 11.2.7.2.3 France Proteomics Market by Services and Software
        • 11.2.7.2.4 France Proteomics Market by Application
      • 11.2.7.3 Italy Proteomics Market
        • 11.2.7.3.1 Italy Proteomics Market by Instrument
        • 11.2.7.3.2 Italy Proteomics Market by Reagents
        • 11.2.7.3.3 Italy Proteomics Market by Services and Software
        • 11.2.7.3.4 Italy Proteomics Market by Application
      • 11.2.7.4 Spain Proteomics Market
        • 11.2.7.4.1 Spain Proteomics Market by Instrument
        • 11.2.7.4.2 Spain Proteomics Market by Reagents
        • 11.2.7.4.3 Spain Proteomics Market by Services and Software
        • 11.2.7.4.4 Spain Proteomics Market by Application
      • 11.2.7.5 United Kingdom Proteomics Market
        • 11.2.7.5.1 United Kingdom Proteomics Market by Instrument
        • 11.2.7.5.2 United Kingdom Proteomics Market by Reagents
        • 11.2.7.5.3 United Kingdom Proteomics Market by Services and Software
        • 11.2.7.5.4 United Kingdom Proteomics Market by Application
      • 11.2.7.6 Rest of Europe Proteomics Market
        • 11.2.7.6.1 Rest of Europe Proteomics Market by Instrument
        • 11.2.7.6.2 Rest of Europe Proteomics Market by Reagents
        • 11.2.7.6.3 Rest of Europe Proteomics Market by Services and Software
        • 11.2.7.6.4 Rest of Europe Proteomics Market by Application
  • 11.3. ASIA-PACIFIC
    • 11.3.1 Asia-Pacific Proteomics Market Overview
    • 11.3.2 Asia-Pacific Proteomics Market Forecasts and Analysis
    • 11.3.3 Asia-Pacific Proteomics Market Forecasts and Analysis - By Instrument
    • 11.3.4 Asia-Pacific Proteomics Market Forecasts and Analysis - By Reagents
    • 11.3.5 Asia-Pacific Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.3.6 Asia-Pacific Proteomics Market Forecasts and Analysis - By Application
    • 11.3.7 Asia-Pacific Proteomics Market Forecasts and Analysis - By Countries
      • 11.3.7.1 Australia Proteomics Market
        • 11.3.7.1.1 Australia Proteomics Market by Instrument
        • 11.3.7.1.2 Australia Proteomics Market by Reagents
        • 11.3.7.1.3 Australia Proteomics Market by Services and Software
        • 11.3.7.1.4 Australia Proteomics Market by Application
      • 11.3.7.2 China Proteomics Market
        • 11.3.7.2.1 China Proteomics Market by Instrument
        • 11.3.7.2.2 China Proteomics Market by Reagents
        • 11.3.7.2.3 China Proteomics Market by Services and Software
        • 11.3.7.2.4 China Proteomics Market by Application
      • 11.3.7.3 India Proteomics Market
        • 11.3.7.3.1 India Proteomics Market by Instrument
        • 11.3.7.3.2 India Proteomics Market by Reagents
        • 11.3.7.3.3 India Proteomics Market by Services and Software
        • 11.3.7.3.4 India Proteomics Market by Application
      • 11.3.7.4 Japan Proteomics Market
        • 11.3.7.4.1 Japan Proteomics Market by Instrument
        • 11.3.7.4.2 Japan Proteomics Market by Reagents
        • 11.3.7.4.3 Japan Proteomics Market by Services and Software
        • 11.3.7.4.4 Japan Proteomics Market by Application
      • 11.3.7.5 South Korea Proteomics Market
        • 11.3.7.5.1 South Korea Proteomics Market by Instrument
        • 11.3.7.5.2 South Korea Proteomics Market by Reagents
        • 11.3.7.5.3 South Korea Proteomics Market by Services and Software
        • 11.3.7.5.4 South Korea Proteomics Market by Application
      • 11.3.7.6 Rest of Asia-Pacific Proteomics Market
        • 11.3.7.6.1 Rest of Asia-Pacific Proteomics Market by Instrument
        • 11.3.7.6.2 Rest of Asia-Pacific Proteomics Market by Reagents
        • 11.3.7.6.3 Rest of Asia-Pacific Proteomics Market by Services and Software
        • 11.3.7.6.4 Rest of Asia-Pacific Proteomics Market by Application
  • 11.4. MIDDLE EAST AND AFRICA
    • 11.4.1 Middle East and Africa Proteomics Market Overview
    • 11.4.2 Middle East and Africa Proteomics Market Forecasts and Analysis
    • 11.4.3 Middle East and Africa Proteomics Market Forecasts and Analysis - By Instrument
    • 11.4.4 Middle East and Africa Proteomics Market Forecasts and Analysis - By Reagents
    • 11.4.5 Middle East and Africa Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.4.6 Middle East and Africa Proteomics Market Forecasts and Analysis - By Application
    • 11.4.7 Middle East and Africa Proteomics Market Forecasts and Analysis - By Countries
      • 11.4.7.1 South Africa Proteomics Market
        • 11.4.7.1.1 South Africa Proteomics Market by Instrument
        • 11.4.7.1.2 South Africa Proteomics Market by Reagents
        • 11.4.7.1.3 South Africa Proteomics Market by Services and Software
        • 11.4.7.1.4 South Africa Proteomics Market by Application
      • 11.4.7.2 Saudi Arabia Proteomics Market
        • 11.4.7.2.1 Saudi Arabia Proteomics Market by Instrument
        • 11.4.7.2.2 Saudi Arabia Proteomics Market by Reagents
        • 11.4.7.2.3 Saudi Arabia Proteomics Market by Services and Software
        • 11.4.7.2.4 Saudi Arabia Proteomics Market by Application
      • 11.4.7.3 U.A.E Proteomics Market
        • 11.4.7.3.1 U.A.E Proteomics Market by Instrument
        • 11.4.7.3.2 U.A.E Proteomics Market by Reagents
        • 11.4.7.3.3 U.A.E Proteomics Market by Services and Software
        • 11.4.7.3.4 U.A.E Proteomics Market by Application
      • 11.4.7.4 Rest of Middle East and Africa Proteomics Market
        • 11.4.7.4.1 Rest of Middle East and Africa Proteomics Market by Instrument
        • 11.4.7.4.2 Rest of Middle East and Africa Proteomics Market by Reagents
        • 11.4.7.4.3 Rest of Middle East and Africa Proteomics Market by Services and Software
        • 11.4.7.4.4 Rest of Middle East and Africa Proteomics Market by Application
  • 11.5. SOUTH AND CENTRAL AMERICA
    • 11.5.1 South and Central America Proteomics Market Overview
    • 11.5.2 South and Central America Proteomics Market Forecasts and Analysis
    • 11.5.3 South and Central America Proteomics Market Forecasts and Analysis - By Instrument
    • 11.5.4 South and Central America Proteomics Market Forecasts and Analysis - By Reagents
    • 11.5.5 South and Central America Proteomics Market Forecasts and Analysis - By Services and Software
    • 11.5.6 South and Central America Proteomics Market Forecasts and Analysis - By Application
    • 11.5.7 South and Central America Proteomics Market Forecasts and Analysis - By Countries
      • 11.5.7.1 Brazil Proteomics Market
        • 11.5.7.1.1 Brazil Proteomics Market by Instrument
        • 11.5.7.1.2 Brazil Proteomics Market by Reagents
        • 11.5.7.1.3 Brazil Proteomics Market by Services and Software
        • 11.5.7.1.4 Brazil Proteomics Market by Application
      • 11.5.7.2 Argentina Proteomics Market
        • 11.5.7.2.1 Argentina Proteomics Market by Instrument
        • 11.5.7.2.2 Argentina Proteomics Market by Reagents
        • 11.5.7.2.3 Argentina Proteomics Market by Services and Software
        • 11.5.7.2.4 Argentina Proteomics Market by Application
      • 11.5.7.3 Rest of South and Central America Proteomics Market
        • 11.5.7.3.1 Rest of South and Central America Proteomics Market by Instrument
        • 11.5.7.3.2 Rest of South and Central America Proteomics Market by Reagents
        • 11.5.7.3.3 Rest of South and Central America Proteomics Market by Services and Software
        • 11.5.7.3.4 Rest of South and Central America Proteomics Market by Application

12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PROTEOMICS MARKET

  • 12.1 North America
  • 12.2 Europe
  • 12.3 Asia-Pacific
  • 12.4 Middle East and Africa
  • 12.5 South and Central America

13. INDUSTRY LANDSCAPE

  • 13.1. MERGERS AND ACQUISITIONS
  • 13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
  • 13.3. NEW PRODUCT LAUNCHES
  • 13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. PROTEOMICS MARKET, KEY COMPANY PROFILES

  • 14.1. THERMO FISHER SCIENTIFIC INC.
    • 14.1.1. Key Facts
    • 14.1.2. Business Description
    • 14.1.3. Products and Services
    • 14.1.4. Financial Overview
    • 14.1.5. SWOT Analysis
    • 14.1.6. Key Developments
  • 14.2. BIO-RAD LABORATORIES, INC.
    • 14.2.1. Key Facts
    • 14.2.2. Business Description
    • 14.2.3. Products and Services
    • 14.2.4. Financial Overview
    • 14.2.5. SWOT Analysis
    • 14.2.6. Key Developments
  • 14.3. AGILENT TECHNOLOGIES
    • 14.3.1. Key Facts
    • 14.3.2. Business Description
    • 14.3.3. Products and Services
    • 14.3.4. Financial Overview
    • 14.3.5. SWOT Analysis
    • 14.3.6. Key Developments
  • 14.4. DANAHER
    • 14.4.1. Key Facts
    • 14.4.2. Business Description
    • 14.4.3. Products and Services
    • 14.4.4. Financial Overview
    • 14.4.5. SWOT Analysis
    • 14.4.6. Key Developments
  • 14.5. PERKINELMER INC.
    • 14.5.1. Key Facts
    • 14.5.2. Business Description
    • 14.5.3. Products and Services
    • 14.5.4. Financial Overview
    • 14.5.5. SWOT Analysis
    • 14.5.6. Key Developments
  • 14.6. MERCK KGAA
    • 14.6.1. Key Facts
    • 14.6.2. Business Description
    • 14.6.3. Products and Services
    • 14.6.4. Financial Overview
    • 14.6.5. SWOT Analysis
    • 14.6.6. Key Developments
  • 14.7. LUMINEX CORPORATION
    • 14.7.1. Key Facts
    • 14.7.2. Business Description
    • 14.7.3. Products and Services
    • 14.7.4. Financial Overview
    • 14.7.5. SWOT Analysis
    • 14.7.6. Key Developments
  • 14.8. GENERAL ELECTRIC COMPANY
    • 14.8.1. Key Facts
    • 14.8.2. Business Description
    • 14.8.3. Products and Services
    • 14.8.4. Financial Overview
    • 14.8.5. SWOT Analysis
    • 14.8.6. Key Developments